BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 16428186)

  • 1. Autoantibodies against inner ear proteins in patients with delayed endolymphatic hydrops and unilateral juvenile deafness.
    Suzuki M; Hanamitsu M; Kitanishi T; Kohzaki H; Kitano H
    Acta Otolaryngol; 2006 Feb; 126(2):117-21. PubMed ID: 16428186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma vasopressin and V2 receptor in the endolymphatic sac in patients with delayed endolymphatic hydrops.
    Kitahara T; Maekawa C; Kizawa K; Horii A; Doi K
    Otol Neurotol; 2009 Sep; 30(6):812-9. PubMed ID: 19638944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed endolymphatic hydrops as a clinical entity.
    Kamei T
    Int Tinnitus J; 2004; 10(2):137-43. PubMed ID: 15732511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delayed endolymphatic hydrops: an analysis of 12 cases].
    Casani A; Fattori B; Berrettini S; De Ciccio M; Vannucci G; Ghilardi PL
    Acta Otorhinolaryngol Ital; 1993; 13(4):297-303. PubMed ID: 8135101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Delayed endolymphatic hydrops].
    Giannoni B; Pagnini P; Vannucchi P
    Acta Otorhinolaryngol Ital; 1998 Aug; 18(4 Suppl 59):66-70. PubMed ID: 10205936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of autoimmunity in contralateral delayed endolymphatic hydrops.
    Harris JP; Aframian D
    Am J Otol; 1994 Nov; 15(6):710-6. PubMed ID: 8572080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preceding profound deafness and co-factors promote development of endolymphatic hydrops in preliminary patients with delayed endolymphatic hydrops.
    Fukushima M; Ito R; Miyaguchi S; Hirai T; Otami Y; Akahani S; Inohara H; Takeda N
    Acta Otolaryngol; 2016 Dec; 136(12):1304-1308. PubMed ID: 27383063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical features in patients with delayed endolymphatic hydrops].
    Takeda N; Koizuka I; Nishiike S; Kitahara T; Horii A; Uno A; Yano H; Taya N; Doi K; Ogino H; Kudo T
    Nihon Jibiinkoka Gakkai Kaiho; 1998 Dec; 101(12):1385-9. PubMed ID: 10025119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A novel method for screening anti-inner ear autoantibody in patients with autoimmune diseases].
    Zou J; Bi A; Wu X; Yang W; Li Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2000 Apr; 35(2):113-6. PubMed ID: 12768666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed endolymphatic hydrops: study and review of clinical implications and surgical treatment.
    Huang TS; Lin CC
    Ear Nose Throat J; 2001 Feb; 80(2):76-8, 81-2, 84 passim. PubMed ID: 11233350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner ear autoantibodies in patients with rapidly progressive sensorineural hearing loss.
    Harris JP; Sharp PA
    Laryngoscope; 1990 May; 100(5):516-24. PubMed ID: 2329911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical detection of humoral autoantibodies in patients with hearing loss in the last hearing ear].
    Bachor E; ten Cate WJ; Gloddek B; Ehsani N
    Laryngorhinootologie; 2000 Mar; 79(3):131-4. PubMed ID: 10763168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Western blot analysis of serum autoantibodies against inner ear antigens in patients with systemic lupus erythematosus].
    Xiao H; Wang J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):236-8. PubMed ID: 8745466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed endolymphatic hydrops. Special emphasis on nystagmus associated with episodes and contribution of chemical labyrinthectomy.
    Reynard P; Karkas A; Gavid M; Lelonge Y; Bertholon P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Oct; 135(5):321-326. PubMed ID: 30172621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Testing of related antibodies against inner ear tissues and clinical observation on autoimmune inner ear disease].
    Zhai SQ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(6):353-5, 382. PubMed ID: 8031589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The lymphocyte transformation test for detecting immunologic inner ear deafness].
    Berger P; Koja S; Rogowski M; Vollrath M
    HNO; 1989 Apr; 37(4):153-7. PubMed ID: 2722576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss.
    Tebo AE; Szankasi P; Hillman TA; Litwin CM; Hill HR
    Clin Exp Immunol; 2006 Dec; 146(3):427-32. PubMed ID: 17100761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma antidiuretic hormone in cases with the early onset of profound unilateral deafness.
    Takeda T; Kakigi A; Nishioka R; Taguchi D; Nishimura M
    Auris Nasus Larynx; 2008 Dec; 35(4):493-9. PubMed ID: 18329206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gadolinium-enhanced inner ear magnetic resonance imaging for evaluation of delayed endolymphatic hydrops, including a bilateral case.
    Fukushima M; Oya R; Akazawa H; Tsuruta Y; Inohara H
    Acta Otolaryngol; 2016; 136(5):451-5. PubMed ID: 26799493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of delayed endolymphatic hydrops: long-term results of hearing and efficacy of hyperbaric oxygenation therapy.
    Fujino K; Naito Y; Endo T; Kanemaru S; Hiraumi H; Tsuji J; Ito J
    Acta Otolaryngol Suppl; 2007 Feb; (557):22-5. PubMed ID: 17453438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.